These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8825930)

  • 1. A large multisite cancer family is linked to BRCA2.
    Tonin P; Ghadirian P; Phelan C; Lenoir GM; Lynch HT; Letendre F; Belanger D; Monté M; Narod SA
    J Med Genet; 1995 Dec; 32(12):982-4. PubMed ID: 8825930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Confirmation of susceptibility locus on chromosome 13 in Australian breast cancer families.
    Grimmond SM; Palmer JM; Walters MK; Scott C; Nancarrow DJ; Teh BT; Elmes C; Pyke C; Khoo SK; Bennett I; Wetzig N; Hayward NK
    Hum Genet; 1996 Jul; 98(1):80-5. PubMed ID: 8682513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes.
    Thorlacius S; Olafsdottir G; Tryggvadottir L; Neuhausen S; Jonasson JG; Tavtigian SV; Tulinius H; Ogmundsdottir HM; Eyfjörd JE
    Nat Genet; 1996 May; 13(1):117-9. PubMed ID: 8673089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage.
    Marcus JN; Watson P; Page DL; Narod SA; Lenoir GM; Tonin P; Linder-Stephenson L; Salerno G; Conway TA; Lynch HT
    Cancer; 1996 Feb; 77(4):697-709. PubMed ID: 8616762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different tumor types from BRCA2 carriers show wild-type chromosome deletions on 13q12-q13.
    Gudmundsson J; Johannesdottir G; Bergthorsson JT; Arason A; Ingvarsson S; Egilsson V; Barkardottir RB
    Cancer Res; 1995 Nov; 55(21):4830-2. PubMed ID: 7585515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13.
    Easton DF; Steele L; Fields P; Ormiston W; Averill D; Daly PA; McManus R; Neuhausen SL; Ford D; Wooster R; Cannon-Albright LA; Stratton MR; Goldgar DE
    Am J Hum Genet; 1997 Jul; 61(1):120-8. PubMed ID: 9245992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent occurrence of BRCA2 linkage in Icelandic breast cancer families and segregation of a common BRCA2 haplotype.
    Gudmundsson J; Johannesdottir G; Arason A; Bergthorsson JT; Ingvarsson S; Egilsson V; Barkardottir RB
    Am J Hum Genet; 1996 Apr; 58(4):749-56. PubMed ID: 8644738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus.
    Kainu T; Juo SH; Desper R; Schaffer AA; Gillanders E; Rozenblum E; Freas-Lutz D; Weaver D; Stephan D; Bailey-Wilson J; Kallioniemi OP; Tirkkonen M; Syrjäkoski K; Kuukasjärvi T; Koivisto P; Karhu R; Holli K; Arason A; Johannesdottir G; Bergthorsson JT; Johannsdottir H; Egilsson V; Barkardottir RB; Johannsson O; Haraldsson K; Sandberg T; Holmberg E; Grönberg H; Olsson H; Borg A; Vehmanen P; Eerola H; Heikkila P; Pyrhönen S; Nevanlinna H
    Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9603-8. PubMed ID: 10944226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An interstitial tandem duplication of 9p23-24 coexists with a mutation in the BRCA2 gene in the germ line of three brothers with breast cancer.
    Savelyeva L; Claas A; Gier S; Schlag P; Finke L; Mangion J; Stratton MR; Schwab M
    Cancer Res; 1998 Mar; 58(5):863-6. PubMed ID: 9500439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of loss of heterozygosity at loci from chromosome arm 13q suggests a possible involvement of BRCA2 in sporadic breast tumors.
    Kerangueven F; Allione F; Noguchi T; Adélaïde J; Sobol H; Jacquemier J; Birnbaum D
    Genes Chromosomes Cancer; 1995 Aug; 13(4):291-4. PubMed ID: 7547638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linkage to BRCA2 region in hereditary male breast cancer.
    Thorlacius S; Tryggvadottir L; Olafsdottir GH; Jonasson JG; Ogmundsdottir HM; Tulinius H; Eyfjord JE
    Lancet; 1995 Aug; 346(8974):544-5. PubMed ID: 7658781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population-based study of risk of breast cancer in carriers of BRCA2 mutation.
    Thorlacius S; Struewing JP; Hartge P; Olafsdottir GH; Sigvaldason H; Tryggvadottir L; Wacholder S; Tulinius H; Eyfjörd JE
    Lancet; 1998 Oct; 352(9137):1337-9. PubMed ID: 9802270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRCA2 mutation in a family with hereditary prostate cancer.
    Grönberg H; Ahman AK; Emanuelsson M; Bergh A; Damber JE; Borg A
    Genes Chromosomes Cancer; 2001 Mar; 30(3):299-301. PubMed ID: 11170288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent loss of heterozygosity at chromosome 13q12-13 with BRCA2 markers in sporadic male breast cancer.
    Prechtel D; Werenskiold AK; Prechtel K; Keller G; Höfler H
    Diagn Mol Pathol; 1998 Feb; 7(1):57-62. PubMed ID: 9646036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRCA1 and BRCA2: penetrating the clinical arena.
    Foulkes WD
    Lancet; 1998 Oct; 352(9137):1325-6. PubMed ID: 9802263
    [No Abstract]   [Full Text] [Related]  

  • 16. Breast cancer genes. Further enigmatic variations.
    Davies K
    Nature; 1995 Dec 21-28; 378(6559):762-3. PubMed ID: 8524409
    [No Abstract]   [Full Text] [Related]  

  • 17. German family study on hereditary breast-ovarian cancer.
    Hamann U; Becher H; Zimmermann T; Pella K; Bastert G; Chang-Claude J
    J Med Genet; 1996 Aug; 33(8):633-5. PubMed ID: 8863152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families.
    Phelan CM; Lancaster JM; Tonin P; Gumbs C; Cochran C; Carter R; Ghadirian P; Perret C; Moslehi R; Dion F; Faucher MC; Dole K; Karimi S; Foulkes W; Lounis H; Warner E; Goss P; Anderson D; Larsson C; Narod SA; Futreal PA
    Nat Genet; 1996 May; 13(1):120-2. PubMed ID: 8673090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRCA2 mutation in Icelandic prostate cancer patients.
    Sigurdsson S; Thorlacius S; Tomasson J; Tryggvadottir L; Benediktsdottir K; Eyfjörd JE; Jonsson E
    J Mol Med (Berl); 1997 Oct; 75(10):758-61. PubMed ID: 9383000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutional genomic instability with inversions, duplications, and amplifications in 9p23-24 in BRCA2 mutation carriers.
    Savelyeva L; Claas A; Matzner I; Schlag P; Hofmann W; Scherneck S; Weber B; Schwab M
    Cancer Res; 2001 Jul; 61(13):5179-85. PubMed ID: 11431357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.